Phibro Animal Health Corp. (PAHC) Social Stream



Phibro Animal Health Corp. (PAHC): $18.37

0.14 (+0.77%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add PAHC to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#12 of 64

in industry

PHIBRO ANIMAL HEALTH CORP (PAHC) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering PHIBRO ANIMAL HEALTH CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-03 2 $23 $17 $20 $11.25 77.78%
2021-11-18 3 $23 $17 $21 $11.25 86.67%
2022-02-11 3 $23 $17 $21 $11.25 86.67%
2022-05-06 3 $23 $18 $21.333 $11.25 89.63%
2022-08-13 3 $23 $18 $21 $11.25 86.67%
2022-09-10 3 $22 $16 $19.666 $11.25 74.81%
2022-09-17 3 $21 $16 $18 $11.25 60%
2022-10-26 3 $21 $14 $17.333 $11.25 54.07%
2022-11-09 3 $20 $14 $17 $11.25 51.11%
2022-11-17 3 $20 $12 $16.333 $11.25 45.18%
2023-02-08 4 $20 $12 $16.75 $11.25 48.89%
2023-02-09 4 $21 $12 $17.25 $11.25 53.33%
2023-08-28 4 $21 $12 $17 $11.25 51.11%
2023-09-05 3 $21 $12 $16.666 $11.25 48.14%
2023-11-09 3 $21 $12 $16.333 $11.25 45.18%
2023-11-10 4 $16 $11 $13.333 $11.25 18.52%
2023-12-07 5 $16 $9 $11.8 $11.25 4.89%
2023-12-15 5 $13 $9 $11.2 $11.25 -0.44%

The Trend in the Analyst Price Target


PAHC's average price target has moved down $5.8 over the prior 13 months.

PAHC reports an average of 20.76% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-27 4 20 12 16.750 15.25 9.84%
2023-05-04 4 21 12 17.000 14.31 18.8%
2023-09-01 4 21 12 16.750 14.51 15.44%
2023-09-05 3 21 12 16.666 13.43 24.1%
2023-11-09 3 21 12 16.333 9.81 66.49%

PAHC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3.6 1 0 1 2 2 5

The Trend in the Broker Recommendations


Over the past 25 months, PAHC's average broker recommendation rating improved by 0.9.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • PHIBRO ANIMAL HEALTH CORP's number of analysts covering the stock is higher than 210.75% of all US stocks.
  • In terms of how PHIBRO ANIMAL HEALTH CORP fares relative to all US stocks, note that its average analyst price target is greater than 414.5% of that group.
  • In the context of Pharmaceutical Products stocks, PHIBRO ANIMAL HEALTH CORP's variance in analysts' estimates is lower than -431.16% of them.
  • PHIBRO ANIMAL HEALTH CORP's upside potential (average analyst target price relative to current price) is greater than 1225.54% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, SAGE, AMPH, and FGEN are the three stocks most similar to PHIBRO ANIMAL HEALTH CORP regarding the price target and analyst recommendation information presented here.

Is PAHC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!